Drug waste minimisation and cost-containment in Medical Oncology: Two-year results of a feasibility study
2008

Reducing Drug Waste in Medical Oncology

Sample size: 29 publication Evidence: moderate

Author Information

Author(s): Fasola Gianpiero, Aita Marianna, Marini Luisa, Follador Alessandro, Tosolini Marina, Mattioni Laura, Mansutti Mauro, Piga Andrea, Brusaferro Silvio, Aprile Giuseppe

Primary Institution: University Hospital of Udine

Hypothesis

Can a structured approach to drug waste minimization lead to significant cost savings in medical oncology?

Conclusion

Implementing a waste minimization protocol resulted in a 45% reduction in drug expenses due to unused drugs.

Supporting Evidence

  • The economic loss due to drug waste equaled 4.8% of the annual drug expenditure.
  • After implementing the waste minimization protocol, drug expenses due to unused drugs decreased by 45%.
  • Six drugs accounted for 74% of the total cost of drug waste.

Takeaway

This study shows that by being careful with how we use cancer drugs, we can save a lot of money and reduce waste.

Methodology

The study involved monitoring drug wastage and implementing corrective measures over two years.

Potential Biases

The study's design may have inherent biases due to its observational nature.

Limitations

The study was conducted at a single center, which may limit the generalizability of the findings.

Participant Demographics

The study involved patients receiving chemotherapy in a medical oncology department.

Digital Object Identifier (DOI)

10.1186/1472-6963-8-70

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication